Literature DB >> 30947184

Vestibular Neuritis: Recent Advances in Etiology, Diagnostic Evaluation, and Treatment.

Trung N Le, Brian D Westerberg, Jane Lea.   

Abstract

Purpose of Chapter: This chapter highlights the recent advances in etiology, diagnostic evaluation, and management of vestibular neuritis (VN). Recent Findings: The viral hypothesis has been strengthened with new evidence as the main etiology of VN. Recent evidence indicates that bedside oculomotor findings play a critical role in differentiating VN from stroke. The implementation of cervical and ocular vestibular evoked myogenic potential, and video head impulse test in vestibular function testing has made it possible to diagnose selective damage of the vestibular nerves. The management of the acute phase of VN is primarily medical, while long-term treatment is designed to improve vestibular compensation. Summary: VN is clearly defined as an important viral inner ear disorder.
© 2019 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30947184     DOI: 10.1159/000490275

Source DB:  PubMed          Journal:  Adv Otorhinolaryngol        ISSN: 0065-3071


  8 in total

1.  Decreased 25-Hydroxyvitamin D Levels in Patients With Vestibular Neuritis.

Authors:  Yunqin Wu; Zhizhou Hu; Minyan Cai; Zhenyi Fan; Weiwei Han; Qiongfeng Guan; Min Zhou; Li Li; Wang Yan; Xiaoxiong Lu
Journal:  Front Neurol       Date:  2019-08-08       Impact factor: 4.003

2.  Clinical application of cVEMPs and oVEMPs in patients affected by Ménière's disease, vestibular neuritis and benign paroxysmal positional vertigo: a systematic review.

Authors:  A Scarpa; F M Gioacchini; E Cassandro; M Tulli; M Ralli; M Re; C Cassandro
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-10       Impact factor: 2.124

Review 3.  Nutraceuticals for Peripheral Vestibular Pathology: Properties, Usefulness, Future Perspectives and Medico-Legal Aspects.

Authors:  Giuseppe Chiarella; Gianmarco Marcianò; Pasquale Viola; Caterina Palleria; Davide Pisani; Vincenzo Rania; Alessandro Casarella; Alessia Astorina; Alfonso Scarpa; Massimiliano Esposito; Monica Salerno; Nunzio Di Nunno; Matteo Bolcato; Amalia Piscopo; Erika Cione; Giovambattista De Sarro; Giulio Di Mizio; Luca Gallelli
Journal:  Nutrients       Date:  2021-10-18       Impact factor: 6.706

4.  Current diagnosis and treatment of vestibular neuritis: a narrative review.

Authors:  Chang Hoon Bae; Hyung Gyun Na; Yoon Seok Choi
Journal:  J Yeungnam Med Sci       Date:  2021-08-09

Review 5.  Neurological vertigo in the emergency room in pediatric and adult age: systematic literature review and proposal for a diagnostic algorithm.

Authors:  Noemi Pellegrino; Vincenzo Di Stefano; Eleonora Rotondo; Alessandro Graziosi; Marianna Gabriella Rispoli; Angelo Torrente; Antonino Lupica; Filippo Brighina; Umberto Raucci; Pasquale Parisi
Journal:  Ital J Pediatr       Date:  2022-07-27       Impact factor: 3.288

6.  Identification of hub genes and pathophysiological mechanism related to acute unilateral vestibulopathy by integrated bioinformatics analysis.

Authors:  Yajing Cheng; Jianrong Zheng; Ying Zhan; Cong Liu; Bihua Lu; Jun Hu
Journal:  Front Neurol       Date:  2022-09-27       Impact factor: 4.086

Review 7.  The pharmacological treatment of acute vestibular syndrome.

Authors:  Pasquale Viola; Federico Maria Gioacchini; Alessia Astorina; Davide Pisani; Alfonso Scarpa; Gianmarco Marcianò; Alessandro Casarella; Emanuele Basile; Vincenzo Rania; Massimo Re; Giuseppe Chiarella
Journal:  Front Neurol       Date:  2022-09-09       Impact factor: 4.086

Review 8.  Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.

Authors:  Giulio Di Mizio; Gianmarco Marcianò; Caterina Palleria; Lucia Muraca; Vincenzo Rania; Roberta Roberti; Giuseppe Spaziano; Amalia Piscopo; Valeria Ciconte; Nunzio Di Nunno; Massimiliano Esposito; Pasquale Viola; Davide Pisani; Giovambattista De Sarro; Milena Raffi; Alessandro Piras; Giuseppe Chiarella; Luca Gallelli
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.